Nel ASA's Management Overhaul and Revenue Test Converge Ahead of Q1 Report

Nel ASA replaces stock options with PSUs for management, focusing on converting its NOK 1.3B order backlog into revenue as it reports Q1 earnings and reviews asset risks.

A significant shake-up in executive compensation at Nel ASA arrives just as the Norwegian electrolyser manufacturer faces a pivotal earnings report. The company has scrapped its old stock option plan for top management, replacing it with a stringent new system of Performance Share Units (PSUs) tied directly to operational performance goals. CEO Håkon Volldal has voluntarily relinquished his previous 1.5 million options in exchange for approximately 3.4 million of these new units, with CFO Kjell Christian Bjørnsen following suit.

This governance shift underscores the central challenge Nel must address when it presents first-quarter figures on Tuesday, April 22. The core issue remains translating a record order backlog into booked revenue. In the fourth quarter, order intake skyrocketed 364% to NOK 686 million, yet revenue from customer contracts simultaneously fell 20% to NOK 330 million. The company’s order book stands at roughly NOK 1.3 billion, and investors are keen to see if this will finally flow to the bottom line.

The timing of the new incentive plan is no coincidence. It forces management to focus squarely on execution as the company burns through its substantial liquidity reserve of about NOK 1.6 billion. This capital provides operational runway but does not guarantee infinite market patience. Recent trading activity shows a flicker of optimism, with shares closing at €0.22 in Frankfurt on Friday, marking a daily gain of over 6% and a weekly advance of roughly 12%. This leaves the price nearly 13% higher over the past twelve months, yet still about 12% below its 52-week high.

Supporting the recent uptick was a fresh order from the United States. Subsidiary Nel Hydrogen US secured a contract worth $7 million to supply electrolyser equipment to Mesure Process. However, analyst sentiment remains cautious. Morgan Stanley recently slashed its price target from NOK 3.50 to NOK 2.00, while Citi reduced its target to NOK 2.40, with both maintaining "Hold" ratings. The consensus target sits at NOK 2.05.

Beyond the revenue question, a specific asset risk looms. Two unused 500-megawatt production lines at the Herøya facility are under review, and a potential impairment charge could further pressure the Q1 results. The scale of any possible writedown is difficult to quantify in advance.

The company’s long-term strategic bet rests on its next-generation technology. Nel has given the final go-ahead to build up to one gigawatt of production capacity at Herøya for its new pressurised alkaline platform. This system promises to slash manufacturing costs by up to 60%, backed by EU funding of €135 million. The commercial launch is scheduled for the first half of 2026, with larger-scale deliveries commencing in 2027.

The virtual investor presentation at 08:00 CET on April 22 will be scrutinised for concrete updates on this timeline. A vague outlook could dampen the recent rally, while a solid operational update, combined with the new performance-driven management structure, may provide the foundation for sustained momentum. Chart support is seen at the 50-day line near €0.19.